Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Sai Praneeth Reddy Bathena"'
Autor:
Sílvia M. Illamola, Susan E. Marino, Samuel P. Callisto, Angela K. Birnbaum, Sai Praneeth Reddy Bathena, Ilo E. Leppik, Christopher M. Barkley
Publikováno v:
J Clin Pharmacol
Drug side effects which impair cognition can lead to diminished quality of life and discontinuation of therapy. Topiramate is an antiepileptic drug which elicits cognitive deficits more frequently than other antiepileptic drugs, impairing multiple co
Autor:
Hongyun Zhao, Amol Tendolkar, Yuxiang Ma, Sai Praneeth Reddy Bathena, Jennifer Sheng, Wenfeng Fang, Li Zhang
Publikováno v:
Oncologist
Lessons Learned The overall safety profiles of ipilimumab 3 mg/kg and 10 mg/kg administered every 3 weeks, were consistent between Chinese patients with solid tumors in the current study and patients from previous U.S. ipilimumab monotherapy studies.
Autor:
Ilo E. Leppik, Richard C. Brundage, Sai Praneeth Reddy Bathena, Angela K. Birnbaum, Jeannine M. Conway, Jae Eun Ahn
Publikováno v:
Epilepsy Research. 147:115-118
Persons in nursing homes receive a number of medications that may interfere with the pharmacokinetics of carbamazepine (CBZ). The aim of our study was to determine factors that may affect the pharmacokinetics of CBZ in elderly nursing home patients.
Publikováno v:
Epilepsy & Behavior. 69:116-120
Objective The incidence of epilepsy is highest in the elderly and the prevalence of epilepsy is higher in nursing home residents than in other cohorts. Co-medications that act in the central nervous system (CNS) are frequently prescribed in this popu
Autor:
Jorge E. Cortes, Philipp le Coutre, Neil P. Shah, Alexander Brun, Oumar Sy, Sai Praneeth Reddy Bathena, Antonio Jiménez-Velasco, Giuseppe Saglio, Elias Jabbour, Irene DeGutis, Massimo Breccia
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:S230
Context In the treatment of CML-CP, early molecular responses to tyrosine kinase inhibitors (TKIs) are associated with improved long-term outcomes, and major molecular response (MMR) at 18 months is an important goal. Obesity may elevate the risk of
Autor:
Sai Praneeth Reddy Bathena, Afolabi O. Ogunleye, Michael D. Weston, D. Roselyn Cerutis, Karmel V. Headen, Yazen Alnouti, Martha E. Nunn, Timothy P. McVaney, Takanari Miyamoto
Publikováno v:
Journal of Periodontology. 86:713-725
The small bioactive lipid lysophosphatidic acid (LPA) plays critical roles in both normal physiology and inflammation in many systems. However, its actions are just beginning to be defined in oral biology and pathophysiology.Microarray analysis was u
Autor:
Angela K. Birnbaum, Jeannine M. Conway, Ilo E. Leppik, Janice B. Schwartz, Sai Praneeth Reddy Bathena, Ghada F. Ahmed, Richard C. Brundage
Publikováno v:
AAPS J
The AAPS journal, vol 19, iss 2
The AAPS journal, vol 19, iss 2
Pharmacokinetic data of gabapentin (GBP) in community-dwelling elderly patients show a significant effect of advanced age on GBP pharmacokinetics due to altered renal function. However, there are no data in elderly nursing home (NH) patients to evalu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57dcde71a33f3f6b519c77b68725de3d
https://europepmc.org/articles/PMC10118240/
https://europepmc.org/articles/PMC10118240/
Autor:
Marco Olivera, Rhishikesh Thakare, Sandeep Mukherjee, Sai Praneeth Reddy Bathena, Yazen Alnouti, Jane L. Meza, Nagsen Gautam
Publikováno v:
Toxicological Sciences. 143:296-307
The role of bile acids (BAs) as biomarkers for liver injury has been proposed for decades. However, the large inter- and intra-individual variability of the BA profile has prevented its clinical application. To this end, we investigated the effect of
Autor:
Sai Praneeth Reddy Bathena, Elias Jabbour, Giuseppe Saglio, Jorge E. Cortes, Alexander Brun, Philipp le Coutre, Neil P. Shah, Massimo Breccia, Irene DeGutis, Oumar Sy, Antonio Jiménez-Velasco
Publikováno v:
Blood. 134:4155-4155
Introduction: Early responses to tyrosine kinase inhibitors (TKIs) are associated with improved long-term outcomes in patients with chronic myeloid leukemia in chronic phase (CML-CP), and guideline recommendations support the achievement of major mol
Publikováno v:
Biomedical Chromatography. 27:900-909
13-197 is a novel NF-κB inhibitor that shows promising in vitro efficacy data against pancreatic cancer. In this study, we characterized the pharmacokinetics, tissue distribution, protein binding and metabolism of 13-197 in mice and rats. A valid, s